Author

Aysha Habib Khan

Professor, Aga Khan University - Cited by 618 - Metabolic Bone Diseases - Osteoporosis - Vitamin D - Rare diseases of bone

Biography

Aysha Habib Khan is affiliated to Aga Khan University Hospital. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
The eccentric Zagreb indices for the subdivision of some graphs and their applications
H Ahmed, A Alsinai, A Khan, HA OthmanApplied Mathematics and Information Sciences 16 (3), 467-472, 2022202
17
2022
Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder
ZUN Khan, P Chand, H Majid, S Ahmed, AH Khan, A Jamil, S Ejaz, ...BMC neurology 22 (1), 1-8, 2022202
11
2022
Practices of vitamin D supplementation leading to vitamin D toxicity: Experience from a Low-Middle Income Country
S Muneer, I Siddiqui, H Majid, N Zehra, L Jafri, AH KhanAnnals of Medicine and Surgery 73, 103227, 2022202
5
2022
Ergonomics of gastrointestinal endoscopies: Musculoskeletal injury among endoscopy physicians, nurses, and technicians
SZ Shah, ST Rehman, A Khan, MM Hussain, M Ali, S Sarwar, S AbidWorld Journal of Gastrointestinal Endoscopy 14 (3), 142, 2022202
5
2022
Publication dynamics: what can be done to eliminate barriers to publishing full manuscripts by the postgraduate trainees of a low-middle income country?
H Majid, L Jafri, S Ahmed, MA Abid, M Aamir, A Ijaz, AH Khan, I SiddiquiBMC research notes 15 (1), 249, 2022202
3
2022
Exogenous triacontanol provides tolerance against arsenic-induced toxicity by scavenging ROS and improving morphology and physiological activities of Mentha arvensis L.
A Nabi, T Aftab, M Masroor, A Khan, M NaeemEnvironmental Pollution 295, 118609, 2022202
3
2022
COVID-19 vaccination acceptance in underserved urban areas of Islamabad and Rawalpindi: Results from a cross-sectional survey
T Kazmi, M Abdullah, AA Khan, RM Safdar, S Afzal, A KhanBMC Public Health (1), 99, 0
2
2022
Industrial Innovation on the Green Transformation of Manufacturing Commerce
T Khan, A Khan, L Wei, T Khan, S AyubJournal of Marketing Strategies 4 (2), 283-304, 2022202
1
2022
FRAX-based intervention thresholds for Pakistan
H Johansson, G Naureen, R Iqbal, L Jafri, AH Khan, M Umer, E Liu, ...Osteoporosis International 33 (), 05-2, 2022202
1
2022
The Stability or Instability of Co-Even Domination in Graphs
SA Imran, A Alsinai, A Omran, A Khan, HA OthmanAppl. Math 6 (3), 473-478, 2022202
1
2022
Paradigm shifts in vitamin d testing and diagnosis: A decade-long observational study
H Majid, MA Abid, N Zehra, S Muneer, L Jafri, AH KhanPakistan Journal of Pathology 33 (), -4, 2022202
1
2022
Impact of currency devaluation on economic growth: Evidence from Pakistan
T Khan, A Khan, L Wei, S Ayub, J Wang, JA ZiaJournal of Marketing Strategies 4 (2), 327-352, 2022202
1
2022
Reference Intervals of Serum TSH from Mixed Distributions Using Truncation Points and the Kolmogorov-Smirnov Distance.
S Ahmed, J Zierk, AH Khan, L Jafri, H Majid, F Ghani, I SiddiquiClinical Laboratory 68 (7), 2022202
1
2022
Disease activity correlates and functionality in patients with rheumatoid arthritis–real-world experience from a South Asian country
N Nasir, H Majid, A Khan, S Awan, M RiazReumatologia/Rheumatology 60 (3), 83-9, 2022202
1
2022
Utilizing augmented artificial intelligence for aminoacidopathies using collaborative laboratory integrated reporting-A cross-sectional study
ZUN Khan, L Jafri, PL Hall, MJ Schultz, S Ahmed, AH Khan, H MajidAnnals of Medicine and Surgery 82, 0465, 2022202
1
2022
Development and validation of standard and real patient gallstone library using Fourier transform infra-red spectroscopy
L Jafri, MA Abid, H Asif, B Hashmi, H Majid, F Ghani, S Ahmed, I Siddiqui, ...BMC gastroenterology 22 (), -8, 2022202
1
2022
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-9 Pneumonia (pilot randomized clinical trial)M Al Ghobain, F Rebh, A Saad, AH Khan, N Mehyar, A Mashhour, I Islam, ...Journal of Infection and Public Health 5 (2), 546-550, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=MNwv1akAAAAJ&hl=en

Cited by
Citations 618
h-index 12
i10-index 17
Open Access Journals